1. Busutti, L., Breccia, A., Stagni, G., and Gattavecchia, E., 1984, Clinical trials with cyclophosphamide and misonidazole combination for maintaining treatment after radiation therapy of lung carcinoma. International Journal of Radiation Oncology, Biology, Physics, 10, 1739?1743.
2. Coleman, C. N., Friedman, M. K., Jacobs, C., Hausley, J., Ignoffo, R., Lebel, S., Hirst, V. K., Gribbel, M., Carter, S. K., and Phillips, T. L., 1983, Phase I trial of intravenous l-phenylalanine mustard plus the sensitizer misonidazole. Cancer Research, 43, 5022?5025.
3. Hill, R. P., and Bush, R. S., 1969, A lung colony assay to determine the radiosensitivity of the cells of a solid tumor. International Journal of Radiation Biology, 15, 435?444.
4. Hill, S. A., and Siemann, D. W., 1984, Chemopotentiation in vivo: no loss of sensitization with fractionation. British Journal of Cancer, 50, 509?517.
5. Hirst, D. G., and Brown, J. M., 1982, The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity. International Journal of Radiation Oncology, Biology, Physics, 8, 639?642.